Control of Carcinogenesis: a Possible Role for the Activated Macrophage

Overview

Journal Science

Specialty Science

Date 1972 Sep 15

PMID 5055947

Citations 33

Authors

J B Hibbs Jr

L H Lambert Jr

J S Remington

Affiliations

Soon will be listed here.

Abstract

Cytotoxic activity of activated mouse macrophages against mouse embryo fibroblasts was tested before and after spontaneous transformation of the fibroblasts in vitro. Activated macrophages caused little or no destruction of untransformed fibroblasts but were markedly cytotoxic to the same fibroblasts after spontaneous transformation. The efferent limb of this cytotoxic reaction appears to be nonimmunologic and to be related to abnormal growth properties rather than to the antigenic composition of target cells.

Citing Articles

Cancer immunoediting by the innate immune system in the absence of adaptive immunity.

OSullivan T, Saddawi-Konefka R, Vermi W, Koebel C, Arthur C, White J J Exp Med. 2012; 209(10):1869-82.

PMID: 22927549 PMC: 3457735. DOI: 10.1084/jem.20112738.

Human breast cancer cell line xenografts as models of breast cancer. The immunobiologies of recipient mice and the characteristics of several tumorigenic cell lines.

Clarke R Breast Cancer Res Treat. 1996; 39(1):69-86.

PMID: 8738607 DOI: 10.1007/BF01806079.

Development of functional diversity in mouse macrophages. Mutual exclusion of two phenotypic states.

Laszlo D, Henson P, Remigio L, WEINSTEIN L, Sable C, Noble P Am J Pathol. 1993; 143(2):587-97.

PMID: 8342604 PMC: 1887021.

Leukemic cell lysis by activated human macrophages: significance of membrane-associated tumor necrosis factor.

Nakabo Y, Harakawa N, Yamamoto K, Okuma M, Uno K, Sasada M Jpn J Cancer Res. 1993; 84(11):1174-80.

PMID: 8276722 PMC: 5919082. DOI: 10.1111/j.1349-7006.1993.tb02818.x.

Circulating immunoreactive and bioassayable opsonic plasma fibronectin during experimental tumour growth.

Saba T, Gregory T, Blumenstock F Br J Cancer. 1980; 41(6):956-65.

PMID: 7426320 PMC: 2010337. DOI: 10.1038/bjc.1980.174.